Business
Hemostemix' "Your Fountain of Youth" Trademark Granted by Switzerland
Calgary, Alberta--(Newsfile Corp. - January 30, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF...
About this update from Hemostemix Inc
[{"type":"text","content":"Hemostemix' \"Your Fountain of Youth\" Trademark Granted by SwitzerlandCalgary, Alberta--(Newsfile Corp. - January 30, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (\"Hemostemix\" or the \"Company\") is pleased to announce its Trademark, Your Fountain of Youth, was granted protection in Switzerland by its Trademark Office. Kwalata Trading Limited, a wholly owned subsidiary of Hemostemix Inc., has received a Statement of Grant of Protection from the Swiss Trademark Office, and notice of the grant from the World Intellectual Property Organization.\"Your Fountain of Youth explains Hemostemix' therapeutic benefit and why we should scale our business,\" said Thomas Smeenk, CEO. \"ACP-01 treats ischemia - the lack of circulation - in the limb as peripheral arterial disease (\"PAD\") or critical limb ischemia, and in the heart as ischemic cardiomyopathy (\"ICM\"). There are approximately 20,000,000 Americans suffering from PAD, and 2,500,000 Americans suffering from ICM, adding 40,000 new cases per year. At $35,000 per ACP-01 treatment, we can scale from manual to automated production of up to 400,000 batches per month to address these markets, which is our business plan following clinical trials,\" Smeenk said. ABOUT HEMOSTEMIXHemostemix is an autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company has developed, patented, and is scaling a patient's blood-based stem cell therapeutics platform that includes angiogenic cell precursors, neuronal cell precursor and cardiomyocyte cell precursors. For more information, please visit www.hemostemix.com. For further information, please contact: Thomas Smeenk, President, CEO & Co-FounderEM: [email protected] PH: 905-580-4170Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined under the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Information: This news release contains \"forward-looking information\" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, included herein are forward-looking information. In particular, this news release contains forward-looking information in relation to: the lead product AC...